uniQure Ownership | Who Owns uniQure?
uniQure Ownership Summary
uniQure is owned by 79.80% institutional investors, 9.23% insiders, and 10.97% retail investors. Vestal point capital, lp is the largest institutional shareholder, holding 9.82% of QURE shares. International Biotechnology Ord is the top mutual fund, with 3.01% of its assets in uniQure shares.
QURE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | uniQure | 79.80% | 9.23% | 10.97% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vestal point capital, lp | 4.75M | 9.82% | $21.28M |
| Blackrock | 1.93M | 3.98% | $8.63M |
| 683 capital management | 1.90M | 3.93% | $8.51M |
| Schroder investment management group | 1.74M | 3.60% | $7.80M |
| Vanguard group | 1.16M | 2.40% | $5.20M |
| Morgan stanley | 1.12M | 2.31% | $5.00M |
| Ameriprise financial | 851.07K | 1.76% | $3.81M |
| Hudson bay capital management lp | 809.12K | 1.67% | $3.62M |
| Macquarie group | 706.17K | 1.46% | $3.16M |
| Jpmorgan chase | 665.58K | 1.38% | $2.98M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vestal point capital, lp | 4.75M | 1.59% | $21.28M |
| Privium fund management b.v. | 640.42K | 0.66% | $2.57M |
| 683 capital management | 1.90M | 0.64% | $8.51M |
| Sonic gp | 50.00K | 0.46% | $224.00K |
| Covestor | 48.27K | 0.14% | $216.00K |
| Nantahala capital management | 243.00K | 0.06% | $1.09M |
| Pfm health sciences, lp | 274.54K | 0.06% | $1.23M |
| Pdt partners | 139.00K | 0.06% | $622.72K |
| Sanders morris harris | 68.07K | 0.05% | $304.95K |
| Shay capital | 69.70K | 0.04% | $312.26K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Schroder investment management group | 1.74M | 0.01% | 498.85K |
| Deutsche bank ag\ | 420.69K | 0.00% | 420.69K |
| Hudson bay capital management lp | 809.12K | 0.02% | 284.12K |
| Verition fund management | 520.42K | 0.01% | 209.85K |
| Norges bank | 207.10K | 0.00% | 207.10K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adar1 capital management | - | - | -1.22M |
| Ikarian capital | - | - | -469.13K |
| Alphacentric advisors | - | - | -460.00K |
| Morgan stanley | 1.12M | 0.00% | -401.92K |
| Bridger management | - | - | -362.35K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deutsche bank ag\ | 420.69K | 0.00% | 420.69K | $1.88M |
| Norges bank | 207.10K | 0.00% | 207.10K | $927.81K |
| Assenagon asset management | 181.95K | 0.00% | 181.95K | $815.12K |
| Centiva capital, lp | 100.00K | 0.01% | 100.00K | $448.00K |
| Mirae asset global etfs | 82.78K | 0.00% | 82.78K | $370.87K |
Sold Out
| Holder | Change |
|---|---|
| Northwestern mutual wealth management | -1.00 |
| Nelson, van denburg & campbell wealth management group | -32.00 |
| Financial gravity asset management | -49.00 |
| Quadrant capital group | -56.00 |
| Visionpoint advisory group | -66.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 141 | 9.30% | 38,878,066 | 22.43% | 79 | 1.85% | 69 | 23.21% | 37 | - |
| Jun 30, 2024 | 129 | -6.52% | 31,756,298 | -1.57% | 65 | 1.44% | 56 | -22.22% | 37 | 15.63% |
| Mar 31, 2024 | 138 | -11.54% | 32,262,781 | -13.94% | 67 | 1.10% | 72 | - | 32 | -43.86% |
| Dec 31, 2023 | 156 | -10.86% | 37,489,885 | 3.53% | 78 | 1.36% | 72 | -22.58% | 57 | 29.55% |
| Sep 30, 2023 | 175 | -13.37% | 36,212,214 | 1.18% | 75 | 1.34% | 93 | -1.06% | 44 | -27.87% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| International Biotechnology Ord | 1.47M | 3.01% | 420.77K |
| Franklin Biotechnology Discv A(acc)USD | 1.25M | 2.57% | 289.50K |
| abrdn Healthcare Investors | 1.08M | 2.22% | 44.06K |
| Vanguard Institutional Extnd Mkt Idx Tr | 736.63K | 1.51% | - |
| Delaware Healthcare I | 706.17K | 1.45% | - |
| Columbia Small Cap Value I | 569.83K | 1.17% | 19.90K |
| Columbia Small Cap Value I A | 569.83K | 1.17% | - |
| abrdn Life Sciences Investors | 532.73K | 1.09% | 19.15K |
| Franklin Biotechnology Discovery A | 528.30K | 1.08% | - |
| AlphaCentric Life Sciences & Hlthcare I | 460.00K | 0.94% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2024 | Kapusta Matthew C | CEO, Managing Director | Sell | $1.50M |
| Dec 09, 2024 | Kapusta Matthew C | CEO, Managing Director | Sell | $26.08K |
| Dec 09, 2024 | KLEMT CHRISTIAN | Chief Financial Officer | Sell | $13.56K |
| Jun 26, 2024 | Abi-Saab Walid | Chief Medical Officer | Sell | $6.31K |
| Jun 17, 2024 | CALOZ PIERRE | Chief Operating Officer | Sell | $14.12K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 3 |
| 2024 Q2 | - | 12 |
| 2024 Q1 | - | 3 |
| 2023 Q4 | - | - |
| 2023 Q3 | - | 2 |
QURE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools